Electrical muscle stimulation: Application and potential role in aging society.

Aging Electrical Muscle Stimulation Muscle Hypertrophy Muscle Training Sarcopenia

Journal

Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology
ISSN: 1873-5711
Titre abrégé: J Electromyogr Kinesiol
Pays: England
ID NLM: 9109125

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 31 03 2021
revised: 29 04 2021
accepted: 14 05 2021
pubmed: 25 9 2021
medline: 1 12 2021
entrez: 24 9 2021
Statut: ppublish

Résumé

Neurodegenerative diseases and sarcopenia become more prevalent as individuals age and, therefore, represent a serious issue for the healthcare system. Several studies have reported the relationship between physical activity and reduced incidence of dementia or cognitive deterioration. Thus, exercise and strength training are most recommended treatments, but it is proving difficult to engage individuals to initiate exercise and strength training. Electrical muscle stimulation (EMS) may provide an alternative and more efficient solution. Although EMS has undergone a decline in use, mainly because of stimulation discomfort, new technologies allow painless application of strong contractions. Such activation can be applied in higher exercise dosages and more efficiently than people are likely to achieve with exercise. Unlike orderly recruitment of motor units (MUs) during low intensity voluntary exercise, EMS activates large fast-twitch MUs with glycolytic fibers preferentially and this could have benefit for prevention and treatment of diabetes and chronic diseases associated with muscle atrophy that ultimately lead to bed-ridden conditions. Recent evidence highlights the potential for EMS to make a major impact on these and other lifestyle related diseases and its role as a useful modality for orthopedic and cardiac rehabilitation. This paper will discuss the potential for EMS to break new ground in effective interventions in these frontiers of medical science.

Identifiants

pubmed: 34560440
pii: S1050-6411(21)00085-7
doi: 10.1016/j.jelekin.2021.102598
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102598

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Toshio Moritani (T)

Professor Emeritus, Graduate School of Human and Environmental Studies, Kyoto University, Kyoto and Visiting Professor, Graduate School of Sports Science, Chukyo University, Toyota, Japan. Electronic address: moritani.toshio.76s@st.kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH